Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2020-07-04 / Cancer Immunol. Immunother. 2020 Jul;Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-07-02 / Signal Transduct Target Ther 2020 Jul;5(1):114Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-07-01 / J Immunother Cancer 2020 07;8(2)Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-06-30 / Expert Rev Anticancer Ther 2020 Aug;20(8):639-646CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
/in Dendritic Cells, Glioblastoma, International Publications /von 2020-06-24 / Mol Ther Oncolytics 2020 Sep;18:295-303Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2020-06-21 / J Control Release 2020 Jun;326:63-74Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
/in Dendritic Cells, International Publications /von 2020-06-15 / Nanomedicine 2020 Jun;29:102240Dendritic cell vaccine as an alternative to opioid analgesia in patients with advanced cervical cancer.
/in Cervical Cancer, Dendritic Cells, International Publications /von 2020-05-29 / J Clin Oncol 38: 2020 (suppl; abstr e18022)Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2020-05-22 / Immunotargets Ther 2020;9:95-104
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de